These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21330294)

  • 1. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
    Smit MD; Maass AH; Hillege HL; Wiesfeld AC; Van Veldhuisen DJ; Van Gelder IC
    Eur J Heart Fail; 2011 May; 13(5):543-50. PubMed ID: 21330294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
    Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
    Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
    Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types.
    Doğan A; Gedikli O; Ozaydin M; Acar G
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):317-22. PubMed ID: 20693126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure.
    Schnorbach J; Fröhlich H; Täger T; Corletto A; Katus HA; Frankenstein L
    ESC Heart Fail; 2019 Aug; 6(4):640-648. PubMed ID: 31259484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined electrical and global markers of dyssynchrony predict clinical response to cardiac resynchronization therapy.
    Bajraktari G; Rönn F; Ibrahimi P; Jashari F; Lindmark K; Jensen SM; Henein MY
    Scand Cardiovasc J; 2014 Oct; 48(5):304-10. PubMed ID: 25117854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
    Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.
    Fung JW; Yip GW; Zhang Q; Fang F; Chan JY; Li CM; Wu LW; Chan GC; Chan HC; Yu CM
    Heart Rhythm; 2008 Jun; 5(6):780-6. PubMed ID: 18467188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
    Corell P; Gustafsson F; Kistorp C; Madsen LH; Schou M; Hildebrandt P
    Int J Cardiol; 2007 May; 117(3):395-402. PubMed ID: 16919342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study.
    Gibson PH; Croal BL; Cuthbertson BH; Rae D; McNeilly JD; Gibson G; Jeffrey RR; Buchan KG; El-Shafei H; Hillis GS
    Am Heart J; 2009 Aug; 158(2):244-51. PubMed ID: 19619701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Zhang Q; Chan CK; Chan I; Chan YS; Kong SL; Sanderson JE; Lam CW
    J Card Fail; 2005 Jun; 11(5 Suppl):S42-6. PubMed ID: 15948100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
    Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
    Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.